Abbott Laboratories (ABT)
107.59
+0.52
(+0.49%)
USD |
NYSE |
Apr 23, 16:00
107.87
+0.28
(+0.26%)
Pre-Market: 08:28
Abbott Laboratories Enterprise Value: 194.31B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 194.31B |
| April 22, 2024 | 193.41B |
| April 19, 2024 | 193.77B |
| April 18, 2024 | 190.29B |
| April 17, 2024 | 191.38B |
| April 16, 2024 | 197.12B |
| April 15, 2024 | 196.57B |
| April 12, 2024 | 196.95B |
| April 11, 2024 | 201.01B |
| April 10, 2024 | 200.52B |
| April 09, 2024 | 202.73B |
| April 08, 2024 | 199.40B |
| April 05, 2024 | 200.58B |
| April 04, 2024 | 198.69B |
| April 03, 2024 | 200.72B |
| April 02, 2024 | 202.00B |
| April 01, 2024 | 202.12B |
| March 31, 2024 | 204.85B |
| March 28, 2024 | 204.85B |
| March 27, 2024 | 204.53B |
| March 26, 2024 | 201.10B |
| March 25, 2024 | 198.51B |
| March 22, 2024 | 199.48B |
| March 21, 2024 | 201.11B |
| March 20, 2024 | 201.10B |
| Date | Value |
|---|---|
| March 19, 2024 | 203.98B |
| March 18, 2024 | 202.73B |
| March 15, 2024 | 208.02B |
| March 14, 2024 | 213.85B |
| March 13, 2024 | 216.12B |
| March 12, 2024 | 217.16B |
| March 11, 2024 | 216.18B |
| March 08, 2024 | 217.51B |
| March 07, 2024 | 217.44B |
| March 06, 2024 | 214.70B |
| March 05, 2024 | 213.21B |
| March 04, 2024 | 215.92B |
| March 01, 2024 | 213.45B |
| February 29, 2024 | 213.49B |
| February 28, 2024 | 215.93B |
| February 27, 2024 | 214.81B |
| February 26, 2024 | 213.57B |
| February 23, 2024 | 214.91B |
| February 22, 2024 | 214.15B |
| February 21, 2024 | 212.15B |
| February 20, 2024 | 210.02B |
| February 16, 2024 | 205.45B |
| February 15, 2024 | 204.81B |
| February 14, 2024 | 202.07B |
| February 13, 2024 | 200.82B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
124.99B
Minimum
Mar 23 2020
259.06B
Maximum
Dec 27 2021
195.62B
Average
196.79B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 109.69B |
| Stryker Corp | 137.30B |
| Intuitive Surgical Inc | 129.04B |
| Insulet Corp | 12.41B |
| Edwards Lifesciences Corp | 51.79B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.225B |
| Revenue (Quarterly) | 9.964B |
| Total Expenses (Quarterly) | 8.578B |
| EPS Diluted (Quarterly) | 0.70 |
| Gross Profit Margin (Quarterly) | 55.21% |
| Profit Margin (Quarterly) | 12.29% |
| Earnings Yield | 2.98% |
| Operating Earnings Yield | 3.38% |
| Normalized Earnings Yield | 3.000 |